RE: Why it might pay to fund P2a ourselves12 Jul 2024 11:03
It's about risk, indeed. Big pharma may not take the total risk, but this could be a possibility given the solid science. However, the market comprises serious investors, LT and ST investors, and traders who all come in and out based on their appetite for risk and reward. Companies do raise funds this way.